There is no cure for HIV. Treatment is highly effective and lifelong, and the small number of people described as cured were treated for cancer rather than for HIV, by a method far too dangerous to use otherwise.
What happened in those cases?
A handful of people, starting with a patient in Berlin, received stem cell transplants for life-threatening blood cancers. The donors carried a rare genetic variation that removes the receptor HIV uses to enter cells. The transplants replaced the immune system with one HIV cannot readily infect, and the virus has not returned in those individuals.
Why is that not a treatment?
Because a stem cell transplant carries a substantial risk of death and requires destroying the existing immune system first. It is only justifiable for someone who needs it for cancer anyway. Suitable donors with the genetic variation are also rare. It has confirmed that a cure is possible in principle without providing a route for anyone else.
Why is HIV so hard to cure?
Because it integrates into the DNA of long-lived cells and sits there inactive, invisible to both the immune system and to treatment. This reservoir persists for decades. Medication stops the virus replicating; it does not remove what is already integrated, which is why stopping treatment leads to rebound.
What is being researched?
Several approaches. Strategies to wake the reservoir so it can be cleared. Broadly neutralising antibodies that target many strains. Gene editing to remove the receptor or the integrated virus. Therapeutic vaccines to train the immune system to control it. All are at trial stage and none is close to general use.
What is remission?
A distinct goal: controlling the virus without daily medication rather than eliminating it. Some trial participants have maintained suppression off treatment for months or years. It is genuinely promising and not something available outside a trial.
What about long-acting treatment?
Not a cure and a real change in practice. Injectable treatment given every two months is available for some people and suits anyone for whom daily tablets are the obstacle. Ask your clinic whether you are eligible.
Should anyone stop treatment?
No, and this needs saying plainly. Stopping leads to the virus rebounding within weeks, damage to the immune system, a return of transmission risk, and a risk of resistance developing. Any change should be planned with your clinic rather than attempted alone.
What about claims of cures online?
Treat with considerable suspicion. Claims involving supplements, diets, alternative medicine or products sold directly are not supported by evidence, and people have died after stopping treatment on the strength of them. Legitimate research is published and conducted through trials rather than sold.
How do you find out about trials?
Through your HIV clinic, which will know what is recruiting and whether you might be eligible. NAM aidsmap reports on research developments reliably and without overstatement.
What is the realistic position?
Someone diagnosed today and starting treatment promptly has a life expectancy close to the general population, takes one tablet a day or an injection every two months, and cannot pass the virus on sexually once suppressed. That is not a cure and it is a long way from where things were.
What should you do with cure news?
Read it with interest and without expectation. Individual cases reported prominently are almost always transplant cases or early trial results, and neither changes what is available. Your clinic will know if anything becomes relevant to you.
The short answer
No cure, active research, and a few cases that proved it is possible without providing a route. Stay on treatment.
What about babies and early treatment?
Cases of apparent remission after very early treatment in infancy have been reported, and in the best-known case the virus eventually returned. They have informed research into the reservoir rather than produced a treatment.
Is a vaccine coming?
Preventive vaccine trials have repeatedly not delivered, and the field has shifted considerable effort towards long-acting injectable prevention instead, which is already in use. That is a more realistic near-term prospect than a vaccine.